Keyword Connections

everolimus

Journals

4

1 journal of chromatography b, analytical technologies in the biomedical and life sciences

2 BMC cancer

3 clinical transplantation

4 japanese journal of clinical oncology

Research Groups

0

No Research Group Connected

Bibliographies

19

1 metastatic renal cell carcinoma: a guide to therapy based on current evidence

2 clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma

3 Randomized Controlled Trial Assessing the Impact of Everolimus and Low Exposure Tacrolimus on Graft Outcomes in Kidney Transplant Recipients.

4 Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit

5 Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan.

6 A new HPLC-MS/MS method for simultaneous determination of Cyclosporine A, Tacrolimus, Sirolimus and Everolimus for routine therapeutic drug monitoring.

7 Optimal dose of everolimus administered with tacrolimus in living donor kidney transplantation

8 Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy

9 Long-term clinical outcomes of everolimus-eluting stent versus paclitaxel-eluting stent in patients undergoing percutaneous coronary interventions: a meta-analysis.

10 Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models

11 Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures.

12 Therapeutic Drug Monitoring of Everolimus: A Consensus Report.

13 [Level of evidence for therapeutic drug monitoring of everolimus].

14 One-year Outcome of Everolimus With Standard-dose Tacrolimus Immunosuppression in De Novo ABO-incompatible Living Donor Kidney Transplantation: A Retrospective, Single-center, Propensity Score Matching Comparison With Mycophenolate in 42 Transplants.

15 Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study

16 functional and histological improvement after everolimus rescue of chronic allograft dysfunction in renal transplant recipients

17 a case of inoperable malignant insulinoma with resistant hypoglycemia who experienced the most significant clinical improvement with everolimus

18 treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus

19 paclitaxel-eluting stent (pes) versus everolimus-eluting stent (ees) in insulin requiring diabetics – are the results different?